Antibodies against matrix metalloproteases (MMP), vascular endothelial growth factor (VEGF), vascular cell adhesion molecule-1 (VCAM), and integrins fused to lipid nanoparticles can be used to specifically target cancer cells of interest [112]. This evidence concerns the gene VEGFA and cancer.